Vasohibin‐2 is required for epithelial–mesenchymal transition of ovarian cancer cells by modulating transforming growth factor‐β signaling
Rie Iida‐Norita(The University of Osaka), Yasufumi Sato(The University of Osaka)
Cited by 34
Related Papers
Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis
|Journal of Clinical Investigation|2004|287
Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis
|Journal of Clinical Investigation|2004|263
Enhanced humoral immunity in breast cancer patients with high serum concentration of anti‐HER2 autoantibody
|Cancer Medicine|2021|13
Development of a Novel and Simple Anti-Metastatic Cancer Treatment Targeting Vasohibin-2
|The Tohoku Journal of Experimental Medicine|2023|3